Huprines: New Dual Action Drugs Against Trypanosomiasis and Malaria
Author Information
Author(s): Defaux Julien, Sala Marta, Formosa Xavier, Galdeano Carles, Taylor Martin C., Alobaid Waleed A.A., Kelly John M., Wright Colin W., Camps Pelayo, Muñoz-Torrero Diego
Primary Institution: Universitat de Barcelona
Hypothesis
Can huprines serve as effective dual acting agents against Trypanosoma brucei and Plasmodium falciparum?
Conclusion
Huprines show moderate potency against T. brucei but limited effectiveness against P. falciparum, indicating potential as dual acting compounds with further development needed.
Supporting Evidence
- Huprines displayed IC50 values against T. brucei in the submicromolar to low micromolar range.
- Two huprines were active against a chloroquine-resistant strain of P. falciparum.
- Huprines exhibited selectivity indices for T. brucei over L6 cells of approximately 15.
Takeaway
Scientists tested a new group of drugs called huprines to see if they could help fight two diseases caused by parasites. They found that while these drugs work well against one disease, they don't work as well against the other.
Methodology
The study evaluated the activity of 19 huprines against cultured forms of T. brucei and P. falciparum, along with cytotoxicity assessments against rat myoblast L6 cells.
Limitations
The huprines showed low selectivity for P. falciparum over L6 cells, limiting their potential as antiplasmodial agents.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website